The Malaysian Reserve

Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)

STOCKHOLM, Sweden, Jan. 26, 2026 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have submitted a proposed Marketing Authorisation Variation to ...

Researchers explore new diagnostic tools, genetic roots for early-onset dementia

Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...

Ontario-based study suggests shingles vaccine prevents or delays new-onset dementia

A new Ontario-based study is suggesting the shingles vaccine may help prevent and/or delay dementia onset more affectedly than any existing treatment.
The Marijuana Herald

Breakdown of Over 500 Peer-Reviewed Cannabis Studies Published in the Past Year

Over the past 12 months, hundreds of peer-reviewed cannabis-related studies have been released, covering everything from pain management and neurological conditions to cancer biology, metabolic health ...
Neurology Advisor

Subcutaneous Lecanemab Starting Dose Under Review for Alzheimer Disease

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

Trump policies at odds with emerging understanding of COVID's long-term harm

Studies offer insights into the health risks and burdens faced by people who have had COVID infections. Meanwhile, the Trump ...